X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.90
Delayed Data
As of Jul 02
 -0.0023 / -0.12%
Today’s Change
1.55
Today|||52-Week Range
5.00
-4.04%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues387.4K282.3K0.000.00
 
 
 
Cost of Goods Sold104.0K108.2K0.000.00
 
 
 
Depreciation And Amortization11.2K10.8K----
 
 
 
 
Operating ExpensesGross Income272.2K163.3K0.000.00
 
 
 
General Expenses865.6K649.3K619.1K348.6K
 
 
 
 
 
Other Operating Expenses0.00-0.000.000.00
 
 
 
Research And Development40.8K42.3K143.8K38.9K
 
 
 
 
 
Total Operating Expenses980.8K768.3K619.1K348.6K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-593.4K-486.0K-619.1K-348.6K
 
 
 
 
 
Extraordinary Charge-143.8K--0.00--
 
 
Other Expenses13.3K-72.8K-102.6K-222.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-723.9K-558.8K-721.7K-571.1K
 
 
 
 
 
Minority Interest-149.9K-57.1K-52.2K-1.9K
 
 
 
 
 
Discontinued Operations0.000.00-115.4K-426.4K
 
 
 
Net Income-574.0K-501.7K-784.9K-999.4K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS11.8M11.9M11.6M11.7M
 
 
 
 
 
Shares To Calculate EPS Diluted11.8M11.9M11.6M11.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.04-$0.04-$0.06-$0.09
 
 
 
 
 
EPS Diluted-$0.04-$0.04-$0.07-$0.09
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account